CM Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-75,000
| Closed | -$1.25M | – | 68 |
|
|
2025
Q1 | $1.25M | Buy |
75,000
+5,000
| +7% | +$83.1K | 1.25% | 35 |
|
|
2024
Q4 | $1.28M | Hold |
70,000
| – | – | 1.15% | 34 |
|
|
2024
Q3 | $1.08M | Buy |
70,000
+30,000
| +75% | +$461K | 0.86% | 42 |
|
|
2024
Q2 | $650K | Hold |
40,000
| – | – | 0.6% | 48 |
|
|
2024
Q1 | $740K | Buy |
40,000
+10,000
| +33% | +$185K | 0.62% | 49 |
|
|
2023
Q4 | $939K | Buy |
+30,000
| New | +$939K | 0.75% | 41 |
|